Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McNamara

Showing results (391-400 of 444) with videos related to

Pageof 45
Sort By:
BMJ Open|February 10, 2026
Protocol for a biomarker discovery study to identify correlates of risk for future tuberculosis disease progression in South African children (INTREPID)Melissa Shea Hamilton, Iena P Derks, Myrsini Kaforou, et al.
Medrxiv : the Preprint Server for Health Sciences|November 1, 2024
Humoral waning kinetics against SARS-CoV-2 is dictated by disease severity and vaccine platformXin Tong, Benjamin Kellman, Maria-Jose Avendano, et al.
JMIR Human Factors|April 9, 2025
Co-Designing a Web-Based and Tablet App to Evaluate Clinical Outcomes of Early Psychosis Service Users in a Learning Health Care Network: User-Centered Design Workshop and Pilot StudyKathleen E Burch, Valerie L Tryon, Katherine M Pierce, et al.
Science Advances|February 23, 2024
Waning immunity and IgG4 responses following bivalent mRNA boostingNinaad Lasrado, Ai-Ris Y Collier, Jessica Miller, et al.
Science Translational Medicine|July 9, 2025
Adenovirus and mRNA vaccines as well as mucosal boosting improve protective efficacy against influenza virus challenge in macaquesCatherine Jacob-Dolan, David Hope, Jinyan Liu, et al.
Nature Communications|January 30, 2024
Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccinationNadège Nziza, Yixiang Deng, Lianna Wood, et al.
Mbio|August 3, 2023
Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concernRyan P McNamara, Jenny S Maron, Julie Boucau, et al.
Science Translational Medicine|October 15, 2025
An intramuscular prime and mucosal boost vaccine regimen protects against lethal clade 2.3.4.4b H5N1 challenge in cynomolgus macaquesNinaad Lasrado, Liping Wang, Jinyan Liu, et al.
NPJ Vaccines|May 21, 2026
Long-term cross-variant Fc-mediated immune responses against SARS-CoV-2 induced by a heterologous adenoviral/inactivated virus prime-boost vaccination strategyDoyoung Kim, Jung Hyuk Lee, Junhyeon Lee, et al.
Schizophrenia Research|February 1, 2025
A mixed-methods study exploring the benefits, drawbacks, and utilization of data in care: Findings from the EPI-CAL early psychosis learning health care networkSabrina Ereshefsky, Regina Gemignani, Mark Savill, et al.
Pageof 45

Showing results (391-400 of 444) with videos related to

Sort By:
Pageof 45
BMJ Open|February 10, 2026
Protocol for a biomarker discovery study to identify correlates of risk for future tuberculosis disease progression in South African children (INTREPID)Melissa Shea Hamilton, Iena P Derks, Myrsini Kaforou, et al.
Medrxiv : the Preprint Server for Health Sciences|November 1, 2024
Humoral waning kinetics against SARS-CoV-2 is dictated by disease severity and vaccine platformXin Tong, Benjamin Kellman, Maria-Jose Avendano, et al.
JMIR Human Factors|April 9, 2025
Co-Designing a Web-Based and Tablet App to Evaluate Clinical Outcomes of Early Psychosis Service Users in a Learning Health Care Network: User-Centered Design Workshop and Pilot StudyKathleen E Burch, Valerie L Tryon, Katherine M Pierce, et al.
Science Advances|February 23, 2024
Waning immunity and IgG4 responses following bivalent mRNA boostingNinaad Lasrado, Ai-Ris Y Collier, Jessica Miller, et al.
Science Translational Medicine|July 9, 2025
Adenovirus and mRNA vaccines as well as mucosal boosting improve protective efficacy against influenza virus challenge in macaquesCatherine Jacob-Dolan, David Hope, Jinyan Liu, et al.
Nature Communications|January 30, 2024
Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccinationNadège Nziza, Yixiang Deng, Lianna Wood, et al.
Mbio|August 3, 2023
Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concernRyan P McNamara, Jenny S Maron, Julie Boucau, et al.
Science Translational Medicine|October 15, 2025
An intramuscular prime and mucosal boost vaccine regimen protects against lethal clade 2.3.4.4b H5N1 challenge in cynomolgus macaquesNinaad Lasrado, Liping Wang, Jinyan Liu, et al.
NPJ Vaccines|May 21, 2026
Long-term cross-variant Fc-mediated immune responses against SARS-CoV-2 induced by a heterologous adenoviral/inactivated virus prime-boost vaccination strategyDoyoung Kim, Jung Hyuk Lee, Junhyeon Lee, et al.
Schizophrenia Research|February 1, 2025
A mixed-methods study exploring the benefits, drawbacks, and utilization of data in care: Findings from the EPI-CAL early psychosis learning health care networkSabrina Ereshefsky, Regina Gemignani, Mark Savill, et al.
Pageof 45